4th Quarter - Amendment
INTERNATIONAL MYELOMA FOUNDATION for INTERNATIONAL MYELOMA FOUNDATION
Income
—
Expenses
$42,005
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Feb 2, 2017 | $45,703 | Replaced |
| 4th Quarter - Amendment (this page) | Feb 2, 2017 | $42,005 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 2739 / S 1566, the Cancer Drug Coverage Parity Act of 2015 - insurance coverage equality for oral anticancer medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBIN R LEVY New | — |
| ANNA KELLEY SIDOROWICZ New | — |
| RAYMOND LEE WEZIK New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.